Bladder Tumor Ag (BTA) Rapid Test

Bladder Tumor Ag (BTA) Rapid Test

Rapid test for qualitative detection of Bladder Tumor Antigen (BTA) in urine as an aid in the monitoring of bladder cancer.

Tumor Markers Point-of-Care CF-04-02ACunder review

Key Features

Bladder cancer biomarker detection
Urine-based screening
Professional use
Point-of-care compatible
+1 more features

Product Overview

Rapid immunochromatographic assay for the qualitative detection of Bladder Tumor Antigen (BTA) in human urine. Intended for professional in-vitro diagnostic use as an aid in monitoring bladder cancer and detecting potential recurrence. Suitable for clinical and laboratory point-of-care settings.

Product Features

Bladder cancer biomarker detection
Urine-based screening
Professional use
Point-of-care compatible
Rapid visual results

Applications

Clinical diagnostics
Point-of-care screening
Emergency diagnostics
Field testing

Specifications coming soon

Detailed technical parameters for this product are not published here yet. Contact us for the IFU, validation summary, or regulatory package.

Request specifications

Documentation & Resources

Download technical documentation, instructions for use, and certification documents.

No documents available

Documents for this product will be available soon.

Request Documentation

Ready to Order Bladder Tumor Ag (BTA) Rapid Test?

Contact our team to discuss your requirements, get pricing information, or find a distributor in your region.